Original Source(s)
Related Content
Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?
A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.
July 8, 2026
-
3 min
Blindness Linked to Higher Loneliness Scores
Analysis of more than 61,000 patients found higher odds of elevated loneliness scores among those reporting blindness and those with diabetic retinopathy, but not among patients with glaucoma or age-related macular degeneration.
June 28, 2026
-
4 min
Mapping the FLIGHT Path
How incision-free intervention could expand glaucoma treatment options
by Julian Upton
June 16, 2026
-
8 min
